From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved ...

Lily Allen is sharing details surrounding a recent visit to a treatment center. The singer discussed the visit on the latest episode of her BBC podcast “Miss Me?” with her cohost Miquita ...

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes ...

Stephen Mandel’s Lone Pine Capital disclosed in an SEC filing its holdings as of December 31, 2024. Lone Pine’s four new buys during the fourth ...

Boris Becker's ex-wife Lilly has won the German version of I'm A Celebrity... Get Me Out Of Here! after stealing the hearts of the nation. The former Wimbledon tennis star, 57, has endured a ...

This is a positive change from Eli Lilly and Company’s previous quarterly dividend of $1.30. This represents a $6.00 annualized dividend and a dividend yield of 0.73%. The ex-dividend date is ...

Eli Lilly LLY-N on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing investor agitation about signs of weakness in sales of the drugs.

“The facilities available to us at Lilly’s top-tier innovation hub, coupled with their expertise and guidance, offer a valuable opportunity to drive Kenai’s growth within the vibrant San ...

SAN DIEGO, February 12, 2025--(BUSINESS WIRE)--Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the ...